SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAGE

NEW YORK, Sept. 9, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE) and certain officers. The class action, filed in the United States District Court for the Southern District…